Cochrane Abstracts
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Non‐absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis. Accessed 15 September 2024.
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis. Accessed September 15, 2024.
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis
Non‐absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis [Internet]. In: Cochrane Abstracts. [cited 2024 September 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
ID - 434060
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Non‐absorbable_disaccharides_versus_placebo_no_intervention_and_lactulose_versus_lactitol_for_the_prevention_and_treatment_of_hepatic_encephalopathy_in_people_with_cirrhosis
DB - Evidence Central
DP - Unbound Medicine
ER -
